HYPOLIPIDEMIC MEDICATIONS: CURRENT USE AND FUTURE PERSPECTIVES. PART 2. A COMMON APPROACHES FOR STATIN’S USING
This article is devoted to discussion about main aspects of current use of 3-hydroxy-3-methylglutaril CoA reductase inhibitors (statins) according last international guidelines. Statin’s base effects on lipid profile, medication regimens, side effects and safety ensuring are represented.
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
Siberian Branch of Russian Academy of Sciences, Research Institute of Internal and Preventive Medicine, branch of the Institute of Cytology and Genetics
2016-06-01
|
| Series: | Атеросклероз |
| Subjects: | |
| Online Access: | https://ateroskleroz.elpub.ru/jour/article/view/17/17 |